How the MCCQE tests immunization
Immunization questions sit in the health promotion and illness prevention dimension, but they appear in pediatrics, obstetrics, internal medicine, emergency medicine and public health stems. The exam rarely asks you to recite a table. It gives you a person at a visit and asks what they should receive today, whether something stops you from giving it, or what to do after an exposure.
Expect five recurring patterns: the well-child visit (which vaccines are due at this age), the pregnant patient (what to give and what to avoid), the contraindication item (a mild cold, an egg allergy or a previous fever offered as a reason to delay), the catch-up item (a newcomer child with incomplete records), and the exposure item (a dirty wound, a measles contact, a baby born to a mother with hepatitis B). Each has a Canadian answer, and the source is the Canadian Immunization Guide.
- Well visit: what is due now, and can several vaccines be given at once (usually yes).
- Pregnancy: Tdap, influenza and RSV options; no live vaccines.
- Contraindications: very few are real; most offered reasons are myths.
- Catch-up: do not restart a series; give what is missing.
- Exposure: tetanus, measles and hepatitis B post-exposure rules.
Who sets the Canadian schedule
The National Advisory Committee on Immunization (NACI) reviews evidence and makes recommendations. The Public Health Agency of Canada publishes them in the Canadian Immunization Guide (CIG), which includes the recommended schedules for infants, children, adolescents and adults. Provinces and territories then decide which vaccines they fund, the exact visit at which each is given, and which combination products they use.
This creates real differences between provinces. Some give hepatitis B in infancy and others through a school program; some use a combined measles, mumps, rubella and varicella vaccine (MMRV) for the second dose; meningococcal products and the timing of school doses vary. The CIG itself notes that its schedule chapter has not yet absorbed every recent NACI statement, including October 2026 advice on routine pediatric hepatitis B vaccination. For the MCCQE, answer with the CIG pattern and expect stems to avoid province-specific details unless they state them.
One practical message runs through the guide: missed opportunities are a bigger problem than over-vaccination. When a stem asks whether to vaccinate today, the default answer is yes unless there is a true contraindication.
Birth to 18 months
Birth. A hepatitis B dose is part of the schedule in programs that start hepatitis B in infancy, and it is essential for any baby whose mother is HBsAg-positive (see the exposure section). RSV protection also starts here: infants under 8 months entering their first RSV season should receive an RSV monoclonal antibody (nirsevimab or clesrovimab) if the gestational parent did not receive the RSVpreF vaccine during pregnancy.
2, 4 and 6 months. The core series is DTaP-IPV-Hib (diphtheria, tetanus, acellular pertussis, inactivated polio and Haemophilus influenzae type b), given as DTaP-HB-IPV-Hib where hepatitis B is included. Rotavirus is given orally at 2 and 4 months (and at 6 months with the three-dose product). Pneumococcal conjugate vaccine (Pneu-C-15 or Pneu-C-20) starts at 2 months. Influenza vaccine is recommended every year from 6 months of age; children under 9 receiving it for the first time need two doses at least 4 weeks apart.
Pneumococcal schedules. For healthy infants the CIG supports doses at 2 and 4 months with a third dose at 12 months, or a 2, 4 and 6 month series with a booster at 12 to 15 months. Infants with risk factors for invasive pneumococcal disease receive Pneu-C-20 on the four-dose schedule.
12 months. The first dose of MMR (or MMRV), the first varicella dose, meningococcal C conjugate (Men-C-C) and the pneumococcal booster. Giving MMR before the first birthday for travel or an outbreak is allowed from 6 months, but that early dose does not count: two more doses are still needed after 12 months.
18 months. The fourth dose of DTaP-IPV-Hib, and the second doses of MMR and varicella in programs that give them here. The CIG allows the second MMR and varicella doses any time from 18 months, but no later than around school entry.
- Rotavirus: first dose from 6 weeks and before 15 weeks of age; all doses before 8 months.
- Doses of the infant series are spaced about 8 weeks apart, with a minimum of 4 weeks when catching up.
- Several injections at one visit are safe and expected; use separate sites.
The Canadian routine schedule at a glance
- BirthHepatitis B and RSV protectionHep B where the program starts in infancy (always if mother HBsAg-positive). RSV monoclonal antibody if no maternal RSVpreF.
- 2, 4, 6 monthsPrimary infant seriesDTaP-IPV-Hib (with or without hep B), rotavirus by mouth, pneumococcal conjugate. Influenza yearly from 6 months.
- 12 monthsFirst live vaccinesMMR (or MMRV), varicella, meningococcal C conjugate, pneumococcal booster.
- 18 monthsBoostersDTaP-IPV-Hib dose 4; second MMR and varicella from 18 months, no later than school entry.
- 4 to 6 yearsSchool entryDTaP-IPV or Tdap-IPV booster; complete MMR and varicella if needed.
- 9 to 17 yearsSchool programsHPV single dose (9 to 20), Men-C-C or Men-C-ACYW around 12, Tdap around 14, hep B if not done.
- AdultsLifelong maintenanceOne adult Tdap, then Td every 10 years; influenza yearly; Tdap every pregnancy; zoster 2 doses from 50.
- 65 and overOlder adult additionsPneumococcal Pneu-C-20 or Pneu-C-21 once; RSV if high risk at 65 to 74 and for all at 75 and over.
Preschool, school and adolescence
4 to 6 years. A booster of DTaP-IPV or Tdap-IPV before school entry, and the second MMR and varicella doses if not already given (MMRV is an alternative).
HPV. The CIG schedule now recommends a single dose of the nonavalent HPV vaccine for people aged 9 to 20 who are not immunocompromised. A two-dose schedule may be considered after discussion. People aged 21 to 26 receive two doses, and those 27 and over can be offered a two-dose series through shared decision-making. Immunocompromised people need more doses. School programs usually deliver HPV in the preteen years, before sexual debut, which is the point the exam likes to test.
Meningococcal and Tdap. Around 12 years, one dose of Men-C-C or the quadrivalent Men-C-ACYW is given even if a conjugate dose was received in infancy. An adolescent Tdap booster is given in the teen years (the CIG table places it around 14).
Hepatitis B. Children aged 9 to 17 who did not complete an infant series receive a school-age series; some products allow a two-dose schedule in younger adolescents. Because NACI issued new pediatric hepatitis B guidance in October 2026, check the current CIG chapter before relying on a specific product schedule.
The adult schedule
Tetanus, diphtheria and pertussis. Every adult should receive one dose of Tdap in adulthood, regardless of how long it has been since their last tetanus-containing vaccine, then a Td booster every 10 years. Pregnancy has its own Tdap rule, below.
Influenza. Every year for all adults without a contraindication, with priority for those at higher risk of complications.
Pneumococcal. One dose of Pneu-C-20 or Pneu-C-21 at 65 years and over, regardless of previous pneumococcal vaccines (wait at least a year after a prior dose). Adults under 65 with a risk condition receive the same single dose: examples include asplenia or sickle cell disease, immunosuppression, HIV, chronic kidney, liver, heart or lung disease (including asthma needing medical care in the past year), diabetes, cochlear implants, smoking, being unhoused, substance use and occupational exposure to metal fumes. Pneumovax 23 was discontinued in Canada in 2025, so older two-vaccine sequences are no longer the answer.
Herpes zoster. The recombinant zoster vaccine is recommended at 50 years and over, two doses given 2 to 6 months apart.
RSV. A single dose for all adults 75 and over, and for adults 65 to 74 at increased risk of severe RSV disease. Adults 18 to 64 at increased risk may receive it after an individual discussion.
MMR and varicella. Adults born in 1970 or later need one dose of MMR, and two doses at least 4 weeks apart if they are health care workers, travellers, post-secondary students or military personnel. Adults born before 1970 are generally presumed immune to measles, except health care workers, who need two documented doses regardless of birth year. Non-immune adults aged 18 to 49 receive two doses of varicella vaccine 6 weeks apart; adults 50 and over are generally presumed immune.
Pregnancy and breastfeeding
Tdap in every pregnancy. Give Tdap in each pregnancy, whatever the person's previous Tdap history, ideally between 27 and 32 weeks of gestation so antibodies cross the placenta to protect the newborn from pertussis. It can be given from 13 weeks if preterm delivery is likely, and at any point up to delivery if it was missed.
Influenza at any stage. Non-live influenza vaccine is recommended in any trimester. If it was missed, give it postpartum as early as possible, ideally before discharge. Live attenuated (intranasal) influenza vaccine is contraindicated in pregnancy.
RSV. The RSVpreF vaccine can be given from 28 through 36 weeks of gestation. Infants whose parent received it generally do not need a monoclonal antibody, unless they have medical risk factors or are born less than 2 weeks after the vaccine.
No live vaccines. MMR, varicella and other live vaccines are generally contraindicated during pregnancy. If a pregnant person receives one by accident, that is not a reason to end the pregnancy. After a live vaccine, people planning pregnancy are advised to avoid conceiving for at least 28 days.
Rubella non-immune. Pregnant people without documented rubella immunity are screened, and if seronegative they receive MMR immediately postpartum before discharge (timing adjusts if they recently received Rh immunoglobulin or other blood products).
Breastfeeding. Most vaccines, including MMR, Tdap, influenza, hepatitis B and pneumococcal vaccines, can be given while breastfeeding. Yellow fever and BCG are among the few generally avoided.
True contraindications and common myths
The CIG list of true contraindications is short. A confirmed anaphylactic reaction to a previous dose of the same vaccine, or a proven anaphylactic allergy to one of its components, is a contraindication. Live vaccines are contraindicated in severe immunocompromise and, in general, in pregnancy. Rotavirus vaccine is contraindicated in infants with a history of intussusception or severe combined immunodeficiency. Guillain-Barre syndrome within 6 weeks of a previous influenza or tetanus vaccine means you do not give further doses of that vaccine.
A moderate or severe acute illness is a precaution, not a contraindication: weigh the timing, and vaccinate once the person improves. A mild illness, with or without fever, is not a reason to delay, nor is a current course of antibiotics.
The myths are where the marks are. Egg allergy is not a contraindication to MMR, MMRV or influenza vaccines, and no skin testing is needed. A previous febrile seizure, prolonged crying or a large local reaction after a vaccine does not prevent future doses. Anticoagulation is not a contraindication: use a fine needle and apply firm pressure for at least 2 minutes. Breastfeeding, prematurity and stable chronic disease are reasons to vaccinate, not to wait.
- Real: anaphylaxis to a prior dose or component; live vaccine in severe immunocompromise or pregnancy; rotavirus after intussusception or SCID.
- Precaution: moderate or severe acute illness; GBS within 6 weeks of influenza or tetanus vaccine.
- Myth: mild cold, antibiotics, egg allergy, prior febrile seizure, anticoagulation, breastfeeding.
Vaccinate or wait? Six classic stems
Catch-up and spacing rules
Newcomer children and adults with missing records are common in Canadian practice and in MCCQE stems. The CIG rule is reassuring: an interrupted series does not need to be restarted. Count the valid documented doses already given, then give what is missing at the minimum intervals. Work from documented doses: ask the family to look for records from the country of origin, and do not let the search delay the doses you can give today.
Spacing between vaccines. Inactivated vaccines can be given at the same visit or at any interval from each other and from live vaccines. Two live injected vaccines (for example MMR and varicella) must be given on the same day or at least 4 weeks apart; a second live injected vaccine given less than 4 weeks after the first is invalid and must be repeated. Live oral or intranasal vaccines can be given with or at any interval from other vaccines.
Doses given too early, before the minimum age, generally do not count and are repeated once the child reaches that age. Blood products and immune globulin can blunt the response to MMR and varicella vaccines, so those vaccines are timed around them.
Exposures and wounds
Tetanus and wounds. Decide two things: is the wound clean and minor, or something else (dirty, deep, crush, burn, bite); and has the patient had at least 3 documented tetanus doses, and how long ago was the last one. With an unknown history or fewer than 3 doses, every wound gets vaccine, and any wound that is not clean and minor also gets tetanus immune globulin. With 3 or more doses, a clean minor wound needs vaccine only if the last dose was more than 10 years ago; any other wound needs vaccine if it was 5 or more years ago. Give immune globulin and vaccine at separate sites. Adults who never had an adult pertussis-containing dose should receive Tdap.
Measles contact. A susceptible person aged 12 months or more should receive MMR within 72 hours of exposure unless contraindicated. Immune globulin within 6 days is considered for pregnant people, immunocompromised people, infants under 6 months, and infants 6 to 11 months who present after 72 hours. Infants 6 to 11 months seen within 72 hours can receive MMR, which will not count toward their routine series.
Hepatitis B and the newborn. A baby born to an HBsAg-positive mother receives hepatitis B vaccine within 12 hours of birth and hepatitis B immune globulin as soon as possible, preferably within 12 hours, followed by further vaccine doses at 1 and 6 months for term infants. Serology to confirm protection is checked after the series, not before 9 months of age. Breastfeeding can continue.
Tetanus prophylaxis for a wound
- 1Classify the woundClean and minor, or any other wound: dirty, deep puncture, crush, burn, bite or devitalized tissue.
- 2Count tetanus dosesUnknown history or fewer than 3 doses: vaccine for every wound, plus TIg if the wound is not clean and minor.
- 33+ doses, clean minor woundGive vaccine only if the last tetanus-containing dose was more than 10 years ago. No TIg.
- 43+ doses, any other woundGive vaccine if the last dose was 5 or more years ago. TIg is generally not needed.
- 5Choose the productUse Tdap if the adult has never had an adult pertussis dose; otherwise Td. Give TIg at a separate site.
- 6Humoral immune deficiencyFor HIV or hypogammaglobulinemia with a wound that is not clean and minor, give both vaccine and TIg.
Special populations the exam returns to
Immunocompromised patients. Inactivated vaccines are safe but may produce a weaker response; live vaccines are avoided in severe immunosuppression. Timing matters: vaccinate before planned immunosuppression or splenectomy where possible. Household contacts should be fully immunized, including against influenza, to protect the patient.
Health care workers. Two documented doses of MMR regardless of birth year, varicella immunity, annual influenza, a Tdap dose, and hepatitis B with a post-vaccination antibody check 1 to 6 months after the series for those who need confirmed immunity. An anti-HBs level of 10 IU/L or more confirms protection. Workers who do not respond after two full series will need passive immunization after a significant exposure.
Older adults. A single visit at 65 is a good moment to check Tdap status, give pneumococcal vaccine, offer the two-dose recombinant zoster series if not done, plan RSV vaccination for those at higher risk now and for everyone at 75, and give the seasonal influenza vaccine.
Answers that look right but are not Canadian
Many candidates learned immunization from another country's schedule. The CIG differs in product choice, timing and dose counts, and exam writers build distractors from those differences. Common errors include giving three HPV doses to a healthy 12-year-old (Canada now uses one dose to age 20), restarting a series after a delay, delaying vaccines because of a cold or an egg allergy, giving MMR to a pregnant patient who is rubella non-immune instead of waiting until after delivery, or offering the old two-vaccine pneumococcal sequence at 65.
When in doubt, return to three CIG principles: vaccinate at every opportunity, never restart a series, and keep live vaccines away from pregnancy and severe immunosuppression.
How the MCCQE frames it: three mini cases
Case 1. A 12-month-old girl comes for her well visit with a runny nose and a temperature of 37.9 C. Her mother asks to postpone the needles. A mild illness with low-grade fever is not a contraindication. The best answer is to give the 12-month vaccines today (MMR, varicella, meningococcal C and the pneumococcal booster) and to explain expected side effects, including the fever or mild rash that can appear a week or so after MMR.
Case 2. A 29-year-old at 30 weeks of gestation had Tdap in her last pregnancy two years ago. It is November. She should receive Tdap now, because it is recommended in every pregnancy, and the influenza vaccine, which is safe in any trimester. Her rubella serology is negative: she should receive MMR after delivery, not now.
Case 3. A 45-year-old carpenter has a deep, soil-contaminated puncture wound. He remembers childhood vaccines but has no records and cannot recall any booster. Unknown history plus a wound that is not clean and minor means tetanus vaccine (Tdap, since he has no adult pertussis dose recorded) and tetanus immune globulin at a separate site, along with wound care.
A one-week plan for immunization
Immunization rewards short, frequent recall. Use 20 minutes a day and test yourself by writing the schedule from memory before checking it.
- Day 1: birth to 18 months; write it out twice from memory.
- Day 2: 4 to 6 years, HPV, adolescent meningococcal and Tdap, school hepatitis B.
- Day 3: adults by decade: Tdap and Td, influenza, zoster at 50, pneumococcal at 65, RSV at 75.
- Day 4: pregnancy and breastfeeding; then true contraindications versus myths.
- Day 5: catch-up and spacing rules, with one newcomer case worked on paper.
- Day 6: tetanus wound table, measles contact, hepatitis B newborn; 25 timed questions in this question bank.
- Day 7: practise a vaccine-hesitant parent counselling script aloud for the NAC.
Sources and further reading
- Canadian Immunization Guide: Recommended immunization schedules
- Canadian Immunization Guide: Timing of vaccine administration
- Canadian Immunization Guide: Contraindications and precautions
- Canadian Immunization Guide: Immunization in pregnancy and breastfeeding
- Canadian Immunization Guide: Tetanus toxoid
- Canadian Immunization Guide: Measles vaccines
- Canadian Immunization Guide: Pneumococcal vaccines
- Canadian Immunization Guide: Hepatitis B vaccines